scholarly journals Improving undergraduate medical education in Nigeria: Insight into the past

2020 ◽  
Vol 37 (1) ◽  
pp. 3
Author(s):  
AkinyinkaO Omigbodun
2021 ◽  
Vol 2 (4) ◽  
pp. 5646-5679
Author(s):  
Bernabe Rios Nava

Los pasados 20 al 23 de Mayo de 2013 evaluadores del Consejo Mexicano para la Acreditación de la Educación Médica (COMAEM), realizaron su proceso de evaluación para la re-acreditación del programa de estudios de la Unidad Académica de Medicina (UAM) de la Universidad Autónoma de Nayarit (UAN). El 8 de noviembre de 2013 en ceremonia oficial, le fue entregada al rector la placa de reconocimiento. Este hecho coloca a la institución como la más importante en la formación médica de pregrado en el estado. El presente trabajo vuelve al pasado y recupera algunas de sus etapas históricas más importantes.   The past 20 al May 23, 2013 evaluators of the Mexican Council for Accreditation of Medical Education (COMAEM) conducted their evaluation process for re-accreditation of the curriculum of the Academic Unit of Medicine (UAM), Autonomus University of Nayarit (UAN). On November 8, 2013 in an official ceremony, the rector was given recognition plaque. This fact puts the institution as the most important in undergraduate medical education in the state. This paper returns to the past and recovers some of its most important historical stages.


2000 ◽  
Vol 34 (12) ◽  
pp. 1016-1018 ◽  
Author(s):  
Harri Hyppola ◽  
Esko Kumpusalo ◽  
Irma Virjo ◽  
Kari Mattila ◽  
Liisa Neittaanmaki ◽  
...  

TAPPI Journal ◽  
2015 ◽  
Vol 14 (1) ◽  
pp. 51-60
Author(s):  
HONGHI TRAN ◽  
DANNY TANDRA

Sootblowing technology used in recovery boilers originated from that used in coal-fired boilers. It started with manual cleaning with hand lancing and hand blowing, and evolved slowly into online sootblowing using retractable sootblowers. Since 1991, intensive research and development has focused on sootblowing jet fundamentals and deposit removal in recovery boilers. The results have provided much insight into sootblower jet hydrodynamics, how a sootblower jet interacts with tubes and deposits, and factors influencing its deposit removal efficiency, and have led to two important innovations: fully-expanded sootblower nozzles that are used in virtually all recovery boilers today, and the low pressure sootblowing technology that has been implemented in several new recovery boilers. The availability of powerful computing systems, superfast microprocessors and data acquisition systems, and versatile computational fluid dynamics (CFD) modeling capability in the past two decades has also contributed greatly to the advancement of sootblowing technology. High quality infrared inspection cameras have enabled mills to inspect the deposit buildup conditions in the boiler during operation, and helped identify problems with sootblower lance swinging and superheater platens and boiler bank tube vibrations. As the recovery boiler firing capacity and steam parameters have increased markedly in recent years, sootblowers have become larger and longer, and this can present a challenge in terms of both sootblower design and operation.


2020 ◽  
Vol 15 ◽  
Author(s):  
Geeta Aggarwal ◽  
Manju Nagpal ◽  
Ameya Sharma ◽  
Vivek Puri ◽  
Gitika Arora Dhingra

Background: Biopharmaceuticals such as Biologic medicinal products have been in clinical use over the past three decades and have benefited towards the therapy of degenerative and critical metabolic diseases. It is forecasted that market of biologics will be going to increase at a rate of 20% per year, and by 2025, more than ˃ 50% of new drug approvals may be biological products. The increasing utilization of the biologics necessitates for cost control, especially for innovators products that have enjoyed a lengthy period of exclusive use. As the first wave of biopharmaceuticals is expired or set to expire, it has led to various opportunities for the expansion of bio-similars i.e. copied versions of original biologics with same biologic activity. Development of biosimilars is expected to promote market competition, meet worldwide demand, sustain the healthcare systems and maintain the incentives for innovation. Methods: Appraisal of published articles from peer reviewed journals, PubMed literature, latest news and guidelines from European Medicine Agency, US Food Drug Administration (FDA) and India are used to identify data for review. Results: Main insight into the quality requirements concerning biologics, current status of regulation of biosimilars and upcoming challenges lying ahead for the upgrading of marketing authorization of bio-similars has been incorporated. Compiled literature on therapeutic status, regulatory guidelines and the emerging trends and opportunities of biosimilars has been thoroughly stated. Conclusion: Updates on biosimilars will support to investigate the possible impact of bio-similars on healthcare market.


Sign in / Sign up

Export Citation Format

Share Document